GSK has received approval from Japan’s MHLW for RSV vaccine Arexvy to prevent RSV disease in adults aged over 60 years ...

Two new vaccines for respiratory syncytial virus (RSV) are available this year for people aged 60 and older, as well as for ...

GSK plc has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Arexvy (respiratory ...

Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus ...

The CDC panel voted to recommend the new maternal vaccine for people who are 32 to 36 weeks pregnant during the RSV season to ...

Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation ...

The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to help protect ...

GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare ...

New Scientist explains how the latest covid-19 booster vaccines are different from previous ones, and who should get them ...

GSK’s Arexvy receives Japanese regulatory approval for prevention of respiratory syncytial virus disease for older adults: London, UK Tuesday, September 26, 2023, 10:00 Hrs [IST ...

Pregnant people should get an RSV vaccine from Pfizer that transfers antibodies to their babies, according to a new CDC ...

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60. Arexvy is a vaccine used for the prevention of respiratory syncytial ...